Skip to main content
Maria Aleman

December 15, 2020

Aleman

Research in the Aleman Lab is centered on basic mechanisms regulating erythropoiesis in health and disease. Differentiation of hematopoietic stem cells down the erythroid track requires coordinated gene expression, including RNA regulation, and accumulation of iron for hemoglobin production. Our current work focuses on a family of bifunctional proteins (poly C binding proteins) which both regulate RNA processing and chaperone iron within cells. Using biochemical, cellular, and in vivo models we explore the cross talk between iron trafficking and RNA regulation mediated by poly C binding proteins and how these activities are modulated by disease.

September 27, 2020

Vaibhav Kumar MD, Hematology-Oncology fellow, publishes study defining improved thresholds for thrombosis prophylaxis in cancer in the ‘The Oncologist’”

The Oncologist “D-dimer enhances risk targeted thromboprophylaxis in ambulatory cancer patients” Background:  Thromboprophylaxis for ambulatory cancer patients is effective, although uncertainties remain on who should be targeted.  using D-dimer values from individuals enrolled to the AVERT trial, we sought to identify and validate a more efficient VTE risk threshold for thromboprophylaxis. Read Publication here